316. カルニチン回路異常症 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 4 / 薬物数 : 5 - (DrugBank : 2) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 10
薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Bezafibrate
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Break IN L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00336167 France
Rigshospitalet, Denmark
2009 Phase 2 NCT00983788 Denmark
Break IN L-carnitine treatment
Karen Lindhardt Madsen
2013 - NCT02226419 -
Glycerol/saline
Oregon Health and Science University
2016 - NCT02517307 United States
Hyperinsulinemic euglycemic clamp
Oregon Health and Science University
2016 - NCT02517307 United States
Intralipid/heparin
Oregon Health and Science University
2016 - NCT02517307 United States